Invention Grant
- Patent Title: Shortened purification process for the production of capsular Streptococcus pneumoniae polysaccharides
- Patent Title (中): 缩短生产荚膜肺炎链球菌多糖的纯化方法
-
Application No.: US12052525Application Date: 2008-03-20
-
Publication No.: US08652480B2Publication Date: 2014-02-18
- Inventor: Yonghui Yuan , Mark Ruppen , Wei-Qiang Sun , Ling Chu , John Simpson , James Patch , Justin Keith Moran , Pamela Fink
- Applicant: Yonghui Yuan , Mark Ruppen , Wei-Qiang Sun , Ling Chu , John Simpson , James Patch , Justin Keith Moran , Pamela Fink
- Applicant Address: US NJ Madison
- Assignee: Wyeth LLC
- Current Assignee: Wyeth LLC
- Current Assignee Address: US NJ Madison
- Agent Royal N. Ronning, Jr.
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K39/00

Abstract:
A shortened process for producing a solution containing substantially purified capsular polysaccharides from a cellular Streptococcus pneumoniae lysate broth is described. Ultrafiltering and diafiltering a clarified S. pneumoniae lysate followed by pH adjustment to less than 4.5, preferably about 3.5, precipitated at least 98% of the protein in the solution without seriously affecting polysaccharide yield. Furthermore, following ultrafiltration and diafiltration and acidification to a pH of less than 4.5, filtration using activated carbon precipitated at least 90% of remaining protein without seriously affecting polysaccharide yield. Exemplary, non-limiting S. pneumoniae serotypes that can be purified using the shortened process of the invention are 1, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. In one embodiment, the Streptococcus pneumoniae cells are lysed using deoxycholate sodium (DOC), while in another embodiment the lytic agent is a non-animal derived lytic agent such as N-lauryl sarcosine sodium (NLS).
Public/Granted literature
- US20080286838A1 SHORTENED PURIFICATION PROCESS FOR THE PRODUCTION OF CAPSULAR STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES Public/Granted day:2008-11-20
Information query